Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Longitudinal Studies01:26

Longitudinal Studies

Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Impact of Model Misspecification on the Individual Causal Association in Surrogate Endpoint Evaluation.

Pharmaceutical statistics·2026
Same author

Time-Scale Target Parameters and Two-Step Estimation in Longitudinal Trials for Progressive Diseases.

Statistics in medicine·2026
Same author

Validation of Optimized Embryo Scoring Procedures: Single-Day versus 2-Day Assessment.

Gynecologic and obstetric investigation·2026
Same author

Primary carE PPi dEprescRibing (PEPPER) trial: a protocol for determining the optimal strategy for stopping chronic proton pump inhibitor therapy in primary care patients.

BMJ open·2026
Same author

Clinical Outcome Associated With Beta-Lactam Allergy Labels in Hospitalized Patients in Belgium.

Clinical and translational allergy·2026
Same author

Visual Biofeedback (VB) through Trans-Perineal Ultrasound (TPU) during the active second stage of labor to improve maternal childbirth satisfaction: protocol of a randomized controlled trial.

BMC pregnancy and childbirth·2026

Related Experiment Video

Updated: Jul 3, 2026

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

Generalizability in nongaussian longitudinal clinical trial data based on generalized linear mixed models.

Tony Vangeneugden1, Geert Molenberghs, Annouschka Laenen

  • 1Tibotec, Johnson & Johnson, Mechelen, Belgium. tvangene@tibbe.jnj.com

Journal of Biopharmaceutical Statistics
|July 9, 2008
PubMed
Summary

This study defines and estimates generalizability using longitudinal clinical trial data. Researchers developed methods to assess how well study results apply to broader populations, focusing on schizophrenia clinical trials.

Related Experiment Videos

Last Updated: Jul 3, 2026

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

Area of Science:

  • Biostatistics
  • Clinical Research Methodology
  • Psychiatric Epidemiology

Background:

  • Generalizability is crucial for applying clinical study findings to real-world populations.
  • Estimating generalizability from longitudinal data presents statistical challenges.
  • Existing methods may not fully capture the nuances of complex longitudinal data.

Purpose of the Study:

  • To define and estimate generalizability as an extension of reliability for longitudinal data.
  • To develop practical methods for assessing generalizability in clinical research.
  • To apply these methods to data from schizophrenia clinical trials.

Main Methods:

  • Utilized generalized linear mixed models to derive approximate expressions for generalizability.
  • Employed longitudinal data sequences from clinical studies.
  • Focused on binary response parameters for estimation.

Main Results:

  • Derived useful and intuitive approximate expressions for estimating generalizability.
  • Successfully applied the methods to estimate generalizability in schizophrenia trials.
  • Demonstrated the feasibility of quantifying generalizability for binary outcomes.

Conclusions:

  • The proposed methods provide a framework for defining and estimating generalizability from longitudinal data.
  • This work enhances the understanding and application of reliability concepts in clinical research.
  • Findings contribute to more robust interpretation of clinical trial results, particularly in psychiatric research.